[1]
R. Kaennak, A. Jetsrisuparp, and S. Srimongkol, “Result of Desferrioxamine Administration by Retained Scalp-vein Into Subcutaneous in Thalassemic Patients”, SRIMEDJ, vol. 35, no. 1, pp. 32–37, Feb. 2020.